15 May 2024 Meeting abstracts: 2024 Annual Congress of the Pulmonary Vascular Research Institute This collection comprises of the 189 accepted abstracts from the PVRI 2024 Annual Congress which took place in London in January 2024. PVRI 2024 London
3 February 2024 SOTERIA: A long-term follow-up study of sotatercept for PAH An oral presentation delivered at PVRI 2024 Congress by Ioana Preston, Tufts University School of Medicine Members Only Member content Register Or Login to view
3 February 2024 Reversal of inflammatory reprogramming at single cell resolution by vasodilator agents in PAH An oral presentation delivered at PVRI 2024 Congress by Anna Kirillova, University of Pittsburgh Members Only Member content Register Or Login to view
3 February 2024 Adding flexibility to PH trials by implementing adaptive designs: overview of opportunities and challenges Presented at PVRI 2024 Congress by Sofia Villar, University of Cambridge Members Only Member content Register Or Login to view
3 February 2024 The ins and outs of PDGF signaling as a therapeutic paradigm Presented at PVRI 2024 Congress by Sophie Nadaud, Sorbonne University and INSERM Members Only Member content Register Or Login to view
3 February 2024 "Liquid Biopsies” during the course of PVD Presented at PVRI 2024 Congress by Corey Ventetuolo, Alpert Medical School, Brown University Members Only Member content Register Or Login to view
3 February 2024 Beyond the clot: CTEPH pathobiology Presented at PVRI 2024 Congress by Andrea Yu, Duke University School of Medicine Members Only Member content Register Or Login to view
3 February 2024 A primer on drug repositioning and repurposing strategies Presented at PVRI 2024 Congress by Steven Corsello, Stanford School of Medicine Members Only Member content Register Or Login to view
3 February 2024 From ‘omics to hypothesis - Insights from molecular & spatial phenotyping Presented at PVRI 2024 Congress by Kerstin Meyer, Wellcome Sanger Institute Members Only Member content Register Or Login to view
3 February 2024 Management and treatment options for low and middle-income countries Presented at PVRI 2024 Congress by Gil Golden, United Therapeutics Corporation Members Only Member content Register Or Login to view
